EU demands Astrazeneca court order to supply vaccine doses

The European Union attacked Astrazeneca Covid-19 vaccine supply “failure” and demanded an urgent order for millions more doses in the latest round of a bitter legal dispute over alleged broken promises by the drugmaker.

Lawyers for Astrazeneca Clemence Van Muylder, Hakim Boularbah and Stephanie De Smedt, arrive to attend a hearing at a Belgian court in the legal case against the British-Swedish firm accused by the EU of having breached its contract for the supply of the coronavirus disease (COVID-19) vaccines, in Brussels, Belgium May 26, 2021. | Photo: Yves Herman/Reuters/Ritzau Scanpix

(Bloomberg) -- At a hearing that kicked off on Wednesday, a Belgian court is weighing EU claims that there’s an emergency situation that merits an order for the drug maker to deliver 20 million more shots than it has promised so far by the end of June. The same court will examine later this year whether Astrazeneca violated the terms of its contract.

“Astrazeneca hasn’t even tried to use all of the tools at its disposal,” the European Commission’s lawyer Rafael Jafferali told a court hearing in Brussels on Wednesday, referring to six production sites in the region that could be used to make deliveries to the EU. The company’s record so far is “obviously a failure.”

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Sanofi reduces US insulin prices for the uninsured

While bills to introduce a price cap on insulin are being discussed in the US Senate, Sanofi has beaten them to the punch and reduced the price of insulin products for US diabetes patients without insurance.

Further reading

Latest news

See all jobs